

7 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| NB Crossroads Private Markets Fund VII Advisory | July 2022 | Indefinite | $29M | 51 |
| NB Crossroads Private Markets Fund VII | February 2022 | Indefinite | $123M | 806 |
| NB Crossroads Private Markets Fund VI Advisory | June 2020 | Indefinite | $33M | 84 |
| NB Crossroads Private Markets Fund VI | February 2020 | Indefinite | $299M | 2,407 |
| NB Crossroads Private Markets Fund V (TI) Advisory |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
7 partners are named across this firm’s filings, 7 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Alan Brott | Quiet | None listed | 0 | 0 |
Too few companies classified yet to infer a focus. 1 of 1 portfolio companies are classified.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of NB Crossroads’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
No other firm shares a filed board seat with NB Crossroads yet. That is a gap in what we have read, not a claim that NB Crossroads invests alone.
A shared board seat: a company where filings name a NB Crossroads partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.
| July 2018 |
| Indefinite |
| $11M |
| 36 |
| NB Crossroads Private Markets Fund V (TE) Advisory | July 2018 | Indefinite | $21M | 44 |
| NB Crossroads Private Markets Fund V (TI) | May 2018 | Indefinite | $173M | 1,109 |
| NB Crossroads Private Markets Fund V (TE) | May 2018 | Indefinite | $101M | 567 |
| NB Crossroads Private Markets Fund IV (TE) - Client | November 2016 | Indefinite | $45M | 311 |
| NB Crossroads Private Markets Fund IV (TI) - Client | November 2016 | Indefinite | $115M | 300 |
| James Bowden | Quiet | Healthcare services | 1 | 0 |
| Mark Bonner | Quiet | None listed | 0 | 0 |
| Thomas McDevitt | Quiet | None listed | 0 | 0 |
| Thomas Yellin | Quiet | None listed | 0 | 0 |
| Victor Imbimbo Jr. | Quiet | None listed | 0 | 0 |
| Virginia Breen | Quiet | None listed | 0 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.